NDC 24090-490

Tirosint

Levothyroxine Sodium

Tirosint is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Akrimax Pharmaceuticals, Llc. The primary component is Levothyroxine Sodium.

Product ID24090-490_a4458922-b538-42d6-b4d3-7942ee950f04
NDC24090-490
Product TypeHuman Prescription Drug
Proprietary NameTirosint
Generic NameLevothyroxine Sodium
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2010-04-01
Marketing CategoryNDA / NDA
Application NumberNDA021924
Labeler NameAkrimax Pharmaceuticals, LLC
Substance NameLEVOTHYROXINE SODIUM
Active Ingredient Strength13 ug/1
Pharm Classesl-Thyroxine [EPC],Thyroxine [CS]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 24090-490-94

2 BLISTER PACK in 1 CARTON (24090-490-94) > 7 CAPSULE in 1 BLISTER PACK
Marketing Start Date2010-04-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 24090-490-99 [24090049099]

Tirosint CAPSULE
Marketing CategoryNDA
Application NumberNDA021924
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2010-04-01
Inactivation Date2020-01-31

NDC 24090-490-94 [24090049094]

Tirosint CAPSULE
Marketing CategoryNDA
Application NumberNDA021924
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2010-04-01
Inactivation Date2020-01-31

NDC 24090-490-77 [24090049077]

Tirosint CAPSULE
Marketing CategoryNDA
Application NumberNDA021924
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2010-04-01
Marketing End Date2010-05-05

NDC 24090-490-84 [24090049084]

Tirosint CAPSULE
Marketing CategoryNDA
Application NumberNDA021924
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2010-04-01
Inactivation Date2020-01-31

NDC 24090-490-07 [24090049007]

Tirosint CAPSULE
Marketing CategoryNDA
Application NumberNDA021924
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2010-04-01
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
LEVOTHYROXINE SODIUM13 ug/1

OpenFDA Data

SPL SET ID:f4d851f6-6bf5-4ed5-8d3a-1646773c4d40
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 905451
  • 905453
  • 905455
  • 905457
  • 905458
  • 1923052
  • 966423
  • 966420
  • 966426
  • 966405
  • 966404
  • 966407
  • 966406
  • 1923047
  • 1923050
  • 1923049
  • 905464
  • 905460
  • 905462
  • 966434
  • 966412
  • 966413
  • 966417
  • 966415

    • Pharmacological Class

    • l-Thyroxine [EPC]
    • Thyroxine [CS]

    Medicade Reported Pricing

    24090049084 TIROSINT 13 MCG CAPSULE

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "Tirosint" or generic name "Levothyroxine Sodium"

    NDCBrand NameGeneric Name
    71858-0005TirosintTirosint
    71858-0060TirosintTirosint
    71858-0015TirosintTirosint
    71858-0040TirosintTirosint
    71858-0020TirosintTirosint
    71858-0035TirosintTirosint
    71858-0055TirosintTirosint
    71858-0025TirosintTirosint
    71858-0030TirosintTirosint
    71858-0050TirosintTirosint
    71858-0010TirosintTirosint
    71858-0045TirosintTirosint
    24090-491TirosintTirosint
    24090-493TirosintTirosint
    24090-494TirosintTirosint
    24090-495TirosintTirosint
    24090-490TirosintTirosint
    24090-492TirosintTirosint
    24090-496TirosintTirosint
    24090-497TirosintTirosint
    24090-498TirosintTirosint
    24090-499TirosintTirosint
    0074-3727SynthroidLevothyroxine Sodium
    0074-4341SynthroidLevothyroxine Sodium
    0074-4552SynthroidLevothyroxine Sodium
    0074-5182SynthroidLevothyroxine Sodium
    0074-6594SynthroidLevothyroxine Sodium
    0074-6624SynthroidLevothyroxine Sodium
    0074-7068SynthroidLevothyroxine Sodium
    0074-7069SynthroidLevothyroxine Sodium

    Trademark Results [Tirosint]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    TIROSINT
    TIROSINT
    79011405 3154257 Live/Registered
    IBSA Institut Biochimique S.A.
    2005-04-22
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.